Incidence of Pulmonary Embolism During Temporary Pacing Via Femoral Versus Subclavian Vein

NCT02430207 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2016-02-19

No results posted yet for this study

Summary

Temporary pacing via femoral vein is used widely in mainland China, because of its feasibility and simplicity. However, pulmonary embolism often occurred after the procedure. It is not known that whether there was any difference in incidence of pulmonary embolism between via different approaches. This randomized and multi-center study was designed to verify whether temporary pacing via subclavian vein has lower incidence than via femoral vein.

Conditions

Interventions

PROCEDURE

temporary pacing femoral vein

Temporary pacing via femoral or subclavian vein

PROCEDURE

temporary pacing subclavian vein

Sponsors & Collaborators

  • Suqian People's Hospital

    collaborator UNKNOWN
  • The First People's Hospital of Kunshan

    collaborator OTHER
  • Danyang People's Hospital of Jiangsu Province

    collaborator UNKNOWN
  • Jiangsu Taizhou People's Hospital

    collaborator OTHER
  • Xinghua People's Hospital

    collaborator UNKNOWN
  • Jiangyin People's Hospital

    collaborator OTHER
  • Qidong People's Hospital

    collaborator UNKNOWN
  • Wuxi No. 2 People's Hospital

    collaborator OTHER
  • Nantong No. 1 People's Hospital

    collaborator UNKNOWN
  • Changzhou No.2 People's Hospital

    collaborator OTHER
  • Xuzhou Medical University

    collaborator OTHER
  • Jiangsu Province Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Northern Jiangsu People's Hospital

    collaborator OTHER
  • Rugao People's Hospital

    collaborator OTHER
  • Xuzhou Central Hospital

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Minglong Chen, M.D. · The First Affiliated Hospital with Nanjing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02430207 on ClinicalTrials.gov